Category:
Prophylactic Biological Products
Gliclazide tablets are oral hypoglycemic agents of the sulfonylurea class, primarily manufactured via crystallization and tablet compression. The active pharmaceutical ingredient features the molecular formula C15H21N3O3S with CAS No. 20968-20-1.
Contraindicated in Type 1 diabetes, diabetic ketoacidosis, and severe renal impairment. Store in a dry environment below 25°C to maintain stability and prevent hydrolysis.